134 related articles for article (PubMed ID: 33896033)
1. Prion protein is associated with a worse prognosis of head and neck squamous cell carcinoma.
Santos EM; Fraga CAC; Xavier AREO; Xavier MAS; Souza MG; Jesus SF; Paula AMB; Farias LC; Santos SHS; Santos TG; Beraldo FH; Guimarães ALS
J Oral Pathol Med; 2021 Nov; 50(10):985-994. PubMed ID: 33896033
[TBL] [Abstract][Full Text] [Related]
2. Syntenin-1 is a promoter and prognostic marker of head and neck squamous cell carcinoma invasion and metastasis.
Cui L; Cheng S; Liu X; Messadi D; Yang Y; Hu S
Oncotarget; 2016 Dec; 7(50):82634-82647. PubMed ID: 27811365
[TBL] [Abstract][Full Text] [Related]
3. LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma.
Sun K; Chen RX; Li JZ; Luo ZX
Hereditas; 2022 Mar; 159(1):16. PubMed ID: 35241179
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of HOX genes promotes cell migration and proliferation in head and neck squamous cell carcinoma.
Aguiar GM; Ramão A; Plaça JR; Simões SC; Scaraboto NV; Freitas-Castro F; Cardoso C; Sousa JF; Silva WA
Tumour Biol; 2021; 43(1):263-278. PubMed ID: 34633333
[TBL] [Abstract][Full Text] [Related]
5. The expression profiles and prognostic values of HSPs family members in Head and neck cancer.
Fan G; Tu Y; Wu N; Xiao H
Cancer Cell Int; 2020; 20():220. PubMed ID: 32523426
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive characterization of the alternative splicing landscape in head and neck squamous cell carcinoma reveals novel events associated with tumorigenesis and the immune microenvironment.
Li ZX; Zheng ZQ; Wei ZH; Zhang LL; Li F; Lin L; Liu RQ; Huang XD; Lv JW; Chen FP; He XJ; Guan JL; Kou J; Ma J; Zhou GQ; Sun Y
Theranostics; 2019; 9(25):7648-7665. PubMed ID: 31695792
[TBL] [Abstract][Full Text] [Related]
7. FOXD1 expression in head and neck squamous carcinoma: a study based on TCGA, GEO and meta-analysis.
Huang J; Liang B; Wang T
Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34269372
[TBL] [Abstract][Full Text] [Related]
8. FDCSP Is an Immune-Associated Prognostic Biomarker in HPV-Positive Head and Neck Squamous Carcinoma.
Wu Q; Shao T; Huang G; Zheng Z; Jiang Y; Zeng W; Lv X
Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291667
[No Abstract] [Full Text] [Related]
9. Sterol regulatory element binding transcription factor 1 promotes proliferation and migration in head and neck squamous cell carcinoma.
Tan M; Lin X; Chen H; Ye W; Yi J; Li C; Liu J; Su J
PeerJ; 2023; 11():e15203. PubMed ID: 37090107
[TBL] [Abstract][Full Text] [Related]
10. FOXD1 is a prognostic biomarker and correlated with macrophages infiltration in head and neck squamous cell carcinoma.
Liang H; Zhang C; Li C; Li C; Wang Y; Lin H
Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34028536
[TBL] [Abstract][Full Text] [Related]
11. Identification of Gene-Tyrosine Kinase 2 (TYK2) in Head and Neck Squamous Cell Carcinoma Patients-An Integrated Bioinformatics Approach.
Gong X; Ren F
Dis Markers; 2022; 2022():5239033. PubMed ID: 35711568
[TBL] [Abstract][Full Text] [Related]
12. Identification of the Potential Correlation between Tumor Protein 73 and Head and Neck Squamous Cell Carcinoma.
Chen Y
Dis Markers; 2022; 2022():6410113. PubMed ID: 35756491
[TBL] [Abstract][Full Text] [Related]
13. Integrative Bioinformatics Analysis Identifies NEK2 as a Potential Biomarker in Head and Neck Squamous Cell Carcinoma.
Liu S; Tian W; Li B
J Comput Biol; 2020 Jan; 27(1):100-108. PubMed ID: 31460782
[TBL] [Abstract][Full Text] [Related]
14. The prognostic value of faciogenital dysplasias as biomarkers in head and neck squamous cell carcinoma.
Ma C; Li H; Li X; Lu S; He J
Biomark Med; 2019 Nov; 13(16):1399-1415. PubMed ID: 31596126
[No Abstract] [Full Text] [Related]
15. CYP4F12 is a potential biomarker and inhibits cell migration of head and neck squamous cell carcinoma via EMT pathway.
Jia W; Chen S; Wei R; Yang X; Zhang M; Qian Y; Liu H; Lei D
Sci Rep; 2023 Jul; 13(1):10956. PubMed ID: 37414830
[TBL] [Abstract][Full Text] [Related]
16. NUTF2 as a Prognostic Indicator and Potential Therapeutic Target in Head and Neck Squamous Cell Carcinoma.
Li P; Wen X; Zhang X; Wang F; Zhang D; Shang H
Genet Test Mol Biomarkers; 2022 Dec; 26(12):553-563. PubMed ID: 36577127
[No Abstract] [Full Text] [Related]
17. Expression and prognostic analysis of BGN in head and neck squamous cell carcinoma.
Zhao L; Liang J; Zhong W; Han C; Liu D; Chen X
Gene; 2022 Jun; 827():146461. PubMed ID: 35358652
[TBL] [Abstract][Full Text] [Related]
18. Profiles of immune cell infiltration in head and neck squamous carcinoma.
Liang B; Tao Y; Wang T
Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32095823
[TBL] [Abstract][Full Text] [Related]
19. MYO5A overexpression promotes invasion and correlates with low lymphocyte infiltration in head and neck squamous carcinoma.
Xing J; Gu Y; Song Y; Liu Q; Chen Q; Han P; Shen Z; Li H; Zhang S; Bai Y; Ma J; Sui F
BMC Cancer; 2023 Dec; 23(1):1267. PubMed ID: 38129784
[TBL] [Abstract][Full Text] [Related]
20. Clinical powers of Aminoacyl tRNA Synthetase Complex Interacting Multifunctional Protein 1 (AIMP1) for head-neck squamous cell carcinoma.
Li Y; Liu H
Cancer Biomark; 2022; 34(3):359-374. PubMed ID: 35068446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]